ArticleJournal of cancer research and clinical oncology2026

GALNT5 drives colorectal cancer progression and chemoresistance via PI3K/Akt/ABCC1 axis.

Qiong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.